SlideShare une entreprise Scribd logo
1  sur  35
Télécharger pour lire hors ligne
BLOOD
TRANSFUSIONBY
Dr. HASSAN TAHA
ANESTHESIA SPECIALIST
OBJECTIVES
 History of blood transfusion
 Purposes for blood transfusion
 Function and properties of blood
 Time of blood transfusion
 Blood component
 Properties and indication of transfusion for every one
 Complications and management of blood transfusion
HISTORYHISTORY The science of blood transfusion dates to the first decade
of the 19th century, with the discovery of distinct blood
types leading to the practice of mixing some blood from
the donor and the receiver before the transfusion.
 First blood transfusion was
done by LOWER in 1665
from dog to dog
 In 1901 Sir Austrian Karl
Landsteiner discovered
blood groups.
 He was awarded nobel
prize for this discovery in
1930.
BLOOD TRANSFUSION
 It is a procedure in which a patient receives a blood product
through an intravenous line.
 It is the introduction of blood components into the venous
circulation.
 Process of transferring blood-based products from one
person into the circulatory system of another.
Blood transfusion
PURPOSES
 To replace blood lost during surgery or a serious injury.
 To restore oxygen-carrying capacity of the blood.
 To provide plasma factors to prevent or treat bleeding.
 Done if patient’s body is not capable of making blood
properly because of an illness or acute los of blood.
FUNCTION AND PROPERTIES OF BLOOD
 A vehicular organ that perfuses all other organs
 Blood and interstitial fluid deliver nutrients to cells and
remove wastes
 Haemostatic governors are carried to and from
appropriate sites
 Blood resembles an average 8% of body weight
FUNCTION OF BLOOD
• TRANSPORT:
 suspended cells include RBCs that carry O2 , One
RBCs can carry 1 billion O2 molecule
 Platelets that contributes to the haemostatic process ,
 Chemicals dissolved in plasma (nutrients, waste,
hormones, etc)
 metabolic heat for disposal
ONE cubic ml of blood contain 400.000 platelets
FUNCTION OF BLOOD
• REGULATION:
 plasma contains pH buffers
 plasma water absorbs heat
 plasma solutes maintain osmolality
FUNCTION OF BLOOD
• PROTECTION:
 plasma precursor proteins form blood clot when
stimulated
 suspended WBCs attack bacteria and viruses ( body’s
defense )
 plasma contains antibodies and opsonins for immunity
Blood transfusion
BEFOR TRANSFUSION WE MUST DETERMINE-
W.H.A.T- FOR ANY PROCEDURE
Blood transfusions can be grouped into two main types
depending on their source:
 Homologous transfusions, or transfusions using the
stored blood of others.
 Autologous transfusions, or transfusions using one's own
stored blood.
BLOOD TRANSFUSIONBLOOD TRANSFUSION
When Hb concentration falls below “acceptable” valuesWhen Hb concentration falls below “acceptable” values
and SaO2 is adequate, SVO2 or oxygen extraction ratioand SaO2 is adequate, SVO2 or oxygen extraction ratio
may be useful in predicting adequate tissue oxygenationmay be useful in predicting adequate tissue oxygenation
20% loss – no need20% loss – no need
20%-30% loss - plasma substitution20%-30% loss - plasma substitution
>30% - Blood transfusion>30% - Blood transfusion
WHENE BLOOD TRANSFUTIONWHENE BLOOD TRANSFUTION
))INDICATIONINDICATION((
.
FRESH WHOLE BLOODFRESH WHOLE BLOOD
 Blood that has been drawn recently (within 24 hours) butBlood that has been drawn recently (within 24 hours) but
NOT separated into its components.NOT separated into its components.
 Contains red blood cells, plasma, clotting cascade factors,Contains red blood cells, plasma, clotting cascade factors,
and plateletsand platelets
 Anticoagulant (CPDA-1)-63mlAnticoagulant (CPDA-1)-63ml
 Hct 35-45% . 1 Unit- 450mlHct 35-45% . 1 Unit- 450ml
 Contents of fresh bloodfresh blood
o RBC’sRBC’s
o WBC’sWBC’s
o PlateletsPlatelets
o PlasmaPlasma
o Clotting factorsClotting factors
If refrigerated within 8 hours of collection, store up to 5 days,If refrigerated within 8 hours of collection, store up to 5 days,
the product only has RBCs and plasma as platelets becomethe product only has RBCs and plasma as platelets become
non-viable at 4oCnon-viable at 4oC
Indications
 Acute loss of whole bloodAcute loss of whole blood
 Massive transfusionMassive transfusion
 Cardiovascular bypass surgeryCardiovascular bypass surgery
1. PACKED RED BLOOD CELL ( PRBCs )PACKED RED BLOOD CELL ( PRBCs )
 (PRBCs) 1 unit contain (250 ml and Hct.70%)
 Healthy, normovolemic individual, tissue oxygenation is
maintained and anemia tolerated at Hct as low as 18-25% (Hb
6gm%).
 RBC transfusion is rarely indicated when Hb > 10 g/dl and is
almost always indicated when Hb < 6 g/dl.
 Fastest way to increase the oxygen-delivering capacity of the blood.Fastest way to increase the oxygen-delivering capacity of the blood.
 A unit of whole blood or packed red cells will raise the hematocriteA unit of whole blood or packed red cells will raise the hematocrite
by 3% and the hemoglobin by 1 gm/dlby 3% and the hemoglobin by 1 gm/dl
 RBCs made and destroyed by a rate of 2-3 million per second .
 D5W lyses RBC’s.
 ONE cubic ml of blood contain 5 million of RBCsONE cubic ml of blood contain 5 million of RBCs
 We have approximately 25-30 trillion RBCs in our blood at any
given time
 Each RBCs has 250 million hemoglobin molecule
 Every hemoglobin molecule can hold 4O2 molecule so one
RBCs can carry 1 billion O2 molecule
 One cubic milliliter of blood has only 5.000-10.000 white
WBCs
Contents
 RBC’s
 20% Plasma
Indications
 Replace O2 carrying capacity
with less volume
 Severe anemia, slow blood loss, CHF
2. FFP ( initial therapeutic dose : 10-15 ml/kg )( initial therapeutic dose : 10-15 ml/kg )
 4-5 units of FFP- in deterioration of normal hemostasis4-5 units of FFP- in deterioration of normal hemostasis
Stored at -30 CStored at -30 C (shelf life of 12 months) . Thawed rapidly at 37 C.shelf life of 12 months) . Thawed rapidly at 37 C.
ONE unit increase coagulation factors 2-3 %ONE unit increase coagulation factors 2-3 %
Infused intravenously through a standard blood set with on-lineInfused intravenously through a standard blood set with on-line
filterfilter
ABO group must be compatibleABO group must be compatible
Infusion of 1 unit should be complete within 4 hr of thawingInfusion of 1 unit should be complete within 4 hr of thawing
 ContentsContents
Clotting factorsClotting factors
FibrinogenFibrinogen
 ProthrombinProthrombin
Albumin & GlobulinsAlbumin & Globulins
 indicationindication
 Isolated factor deficienciesIsolated factor deficiencies
 Reverse warfarin therapyReverse warfarin therapy
 Correction of coagulopathy associated with liver diseaseCorrection of coagulopathy associated with liver disease
 Used in patients who are received massive bloodUsed in patients who are received massive blood
transfusion with microvascular bleedingtransfusion with microvascular bleeding
 Antithrombin III deficiencyAntithrombin III deficiency
 TTP ( Thrombotic thrombocytopenic purpura )TTP ( Thrombotic thrombocytopenic purpura )
## Do not use for volumeDo not use for volume
3. platelets
1 unit (50-70 ml, stored at +20 to +24c for 5 days)1 unit (50-70 ml, stored at +20 to +24c for 5 days)
 indicationindication
 thrombocytopenia or dysfunction platelets inthrombocytopenia or dysfunction platelets in
the presence bleedingthe presence bleeding
 prophylactic : plt. counts below 10,000 to 20,000prophylactic : plt. counts below 10,000 to 20,000
 prophylacticprophylactic preoperative : plt. counts belowpreoperative : plt. counts below 50,00050,000
 Microvascular bleeding in surgical patientMicrovascular bleeding in surgical patient
with platelets < 50,000with platelets < 50,000
 Neuro/ ocular surgery > 75,000Neuro/ ocular surgery > 75,000
4. Cryoprecipitate4. Cryoprecipitate
 Concentrate of factor VIII, von Willebrand’s factor and fibrinogenConcentrate of factor VIII, von Willebrand’s factor and fibrinogen
 20 ml containing 150-300 mg of fibrinogen and 80-120 IU of factor VIII20 ml containing 150-300 mg of fibrinogen and 80-120 IU of factor VIII
 Stored at -30 C (shelf life 12 month)Stored at -30 C (shelf life 12 month)
 Also thawed at 37 CAlso thawed at 37 C
 1U/ 10kg1U/ 10kg ↑↑ fibrinogen 50 mg/dL (usually a 6- pack)fibrinogen 50 mg/dL (usually a 6- pack)
 Transfusion should be complete within 4 hourTransfusion should be complete within 4 hour
indicationsindications
 Hemophilia AHemophilia A
 Factor XIII deficiencyFactor XIII deficiency
Hypofibrinogenemia (congenital or acquired)Hypofibrinogenemia (congenital or acquired)
Microvascular bleeding (fibrinogen < 80-100mg/dL)Microvascular bleeding (fibrinogen < 80-100mg/dL)
Blood transfusion
Complication of Blood Transfusion
A. Immediate reactions
– Febrile reactionFebrile reaction
– Allergic reactionsAllergic reactions
– Hemolytic transfusion reactionHemolytic transfusion reaction
– Circulatory over loadCirculatory over load
– Air embolismAir embolism
– Potassium toxicityPotassium toxicity
– Citrate toxicityCitrate toxicity
– Reaction due to infected bloodReaction due to infected blood
B-Delayed transfusion reactions
ThrombophlebitisThrombophlebitis
infectioninfection
-- AIDS (HIV) Hepatitis (HBV, HCV)AIDS (HIV) Hepatitis (HBV, HCV)
-- Syphilis (Treponema pallidum / Spirochetes)Syphilis (Treponema pallidum / Spirochetes)
-- Malaria , C.M.V & otherMalaria , C.M.V & other
Immunological sensitization or alloimmunizationImmunological sensitization or alloimmunization
Post transfusion purpuraPost transfusion purpura
hemolytic transfusion reactions (HTR)hemolytic transfusion reactions (HTR)
Complication of massive transfusionComplication of massive transfusion
Hemolytic transfusion reactions (HTR)
• Incompatibility between donors and recipient
99% of causes is human error and preventable by
•
 Adequate knowledge of blood groupsAdequate knowledge of blood groups
 Careful attention to all details of the techniquesCareful attention to all details of the techniques
- blood group incompatibility- blood group incompatibility
- outdated and infected blood- outdated and infected blood
- Haemolysed blood- Haemolysed blood
- Incorrect anticoagulant- Incorrect anticoagulant
Chills & rigorsChills & rigors
Chest painChest pain
Back painBack pain
Nausea, vomitingNausea, vomiting
Flushing, sweatingFlushing, sweating
Pain at infusion sitePain at infusion site
Abdominal discomfortAbdominal discomfort
Anxiety & RestlessnessAnxiety & Restlessness
Symptoms of hemolytic transfusion reactionsSymptoms of hemolytic transfusion reactions

SignsSigns
Fever with rigorsFever with rigors
TachycardiaTachycardia
DyspnoeaDyspnoea
TachypnoeaTachypnoea
PallorPallor
HypotensionHypotension
HemoglobinuriaHemoglobinuria
Anuria / OliguriaAnuria / Oliguria
CyanosisCyanosis
Shock & DICShock & DIC
Unexplained bleedingUnexplained bleeding
 Under anesthesia and sedationUnder anesthesia and sedation
 Bleeding from wound / needle sitesBleeding from wound / needle sites
 Persistent hypotensionPersistent hypotension
 Tachycardia, hyperthermiaTachycardia, hyperthermia
Lab evidenceLab evidence
 direct antiglobulin test ( DAT ) positivedirect antiglobulin test ( DAT ) positive
 Indirect bilirubin increasedIndirect bilirubin increased
 HemoglobinemiaHemoglobinemia
 HemoglobinuriaHemoglobinuria
ManagementManagement
 Stop transfusion immediatelyStop transfusion immediately
 Maintain IV access with crystalloidMaintain IV access with crystalloid
 Maintain BP, pulseMaintain BP, pulse
 Ventilation & oxygenationVentilation & oxygenation
 IV diuretics - mannitol IVIV diuretics - mannitol IV
 frusemide IV bolusfrusemide IV bolus
 Send blood samples to blood bank-5ml of plain blood &Send blood samples to blood bank-5ml of plain blood &
2ml of EDTA blood2ml of EDTA blood
 CBC and blood pictureCBC and blood picture
 Urine sample for hemoglobinuria
If intravascular hemolysis is confirmedIf intravascular hemolysis is confirmed
 Monitor renal statusMonitor renal status
 Monitor coagulation statusMonitor coagulation status
 If Hb is markedly reduced ,compatible red cell transfusionIf Hb is markedly reduced ,compatible red cell transfusion
may be required to combat hypoxemia.may be required to combat hypoxemia.
 Treat DIC if it occursTreat DIC if it occurs
Don’ts for Blood TransfusionDon’ts for Blood Transfusion
 Don’t use blood without mandatory screening test.Don’t use blood without mandatory screening test.
 Don’t delay initiation of blood transfusion.Don’t delay initiation of blood transfusion.
 Don’t warm blood without proper monitoring.Don’t warm blood without proper monitoring.
 Don’t transfuse 1 unit over more than 4 hours.Don’t transfuse 1 unit over more than 4 hours.
 Don’t use 1 transfusion set for >4 hours or >2 units ofDon’t use 1 transfusion set for >4 hours or >2 units of
blood.blood.
 Don’t leave patients unmonitored.Don’t leave patients unmonitored.
 Don’t add any medication to blood bags.Don’t add any medication to blood bags.
 Don’t forget to return unused blood to the blood bank forDon’t forget to return unused blood to the blood bank for
safe disposal.safe disposal.
 Don’t store platelets in a refrigerator.Don’t store platelets in a refrigerator.
Blood transfusion

Contenu connexe

Tendances

Massive Transfusion Protocol + Blood transfusions
Massive Transfusion Protocol + Blood transfusionsMassive Transfusion Protocol + Blood transfusions
Massive Transfusion Protocol + Blood transfusionsDavid Hersey
 
Use of blood components in clinical practice - Part 2
Use of blood components in clinical practice - Part 2Use of blood components in clinical practice - Part 2
Use of blood components in clinical practice - Part 2Dr. Varughese George
 
Complication of transfusion
Complication of transfusionComplication of transfusion
Complication of transfusionMulugeta Gobezie
 
Blood transfusion - components , procedure , pre transfusion testing and comp...
Blood transfusion - components , procedure , pre transfusion testing and comp...Blood transfusion - components , procedure , pre transfusion testing and comp...
Blood transfusion - components , procedure , pre transfusion testing and comp...prasanna lakshmi sangineni
 
Blood and blood products presentation ppt
Blood and blood products presentation pptBlood and blood products presentation ppt
Blood and blood products presentation pptankit4089
 
Lethal triad case study no questions
Lethal triad case study no questionsLethal triad case study no questions
Lethal triad case study no questionsChloe Buechler
 
AUTOLOGOUS BLOOD TRANSFUSION
AUTOLOGOUS BLOOD TRANSFUSIONAUTOLOGOUS BLOOD TRANSFUSION
AUTOLOGOUS BLOOD TRANSFUSIONManan Shah
 
Blood, Blood transfusion and Blood products
Blood, Blood transfusion and Blood products  Blood, Blood transfusion and Blood products
Blood, Blood transfusion and Blood products bijay19
 
Management of massive blood loss
Management of massive blood lossManagement of massive blood loss
Management of massive blood losssripalidassa
 
Blood products and massive blood transfusion
Blood products and massive blood transfusionBlood products and massive blood transfusion
Blood products and massive blood transfusionNaveen Kumar Adepu
 
Autologous Blood Transfusion
Autologous Blood TransfusionAutologous Blood Transfusion
Autologous Blood Transfusionleenatayshete
 
blood and blood products
blood and blood productsblood and blood products
blood and blood productsBISHAL SAPKOTA
 

Tendances (20)

Cell salvage
Cell salvageCell salvage
Cell salvage
 
Cardiopulmonary bypass
Cardiopulmonary bypassCardiopulmonary bypass
Cardiopulmonary bypass
 
Massive Transfusion Protocol + Blood transfusions
Massive Transfusion Protocol + Blood transfusionsMassive Transfusion Protocol + Blood transfusions
Massive Transfusion Protocol + Blood transfusions
 
Use of blood components in clinical practice - Part 2
Use of blood components in clinical practice - Part 2Use of blood components in clinical practice - Part 2
Use of blood components in clinical practice - Part 2
 
Complication of transfusion
Complication of transfusionComplication of transfusion
Complication of transfusion
 
Safe Blood Transfusion
Safe Blood TransfusionSafe Blood Transfusion
Safe Blood Transfusion
 
Blood products in Trauma
Blood products in TraumaBlood products in Trauma
Blood products in Trauma
 
Blood transfusion - components , procedure , pre transfusion testing and comp...
Blood transfusion - components , procedure , pre transfusion testing and comp...Blood transfusion - components , procedure , pre transfusion testing and comp...
Blood transfusion - components , procedure , pre transfusion testing and comp...
 
Blood and blood products presentation ppt
Blood and blood products presentation pptBlood and blood products presentation ppt
Blood and blood products presentation ppt
 
Lethal triad case study no questions
Lethal triad case study no questionsLethal triad case study no questions
Lethal triad case study no questions
 
blood products
blood products blood products
blood products
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
AUTOLOGOUS BLOOD TRANSFUSION
AUTOLOGOUS BLOOD TRANSFUSIONAUTOLOGOUS BLOOD TRANSFUSION
AUTOLOGOUS BLOOD TRANSFUSION
 
Blood, Blood transfusion and Blood products
Blood, Blood transfusion and Blood products  Blood, Blood transfusion and Blood products
Blood, Blood transfusion and Blood products
 
Blood component therapy part I
Blood component therapy part IBlood component therapy part I
Blood component therapy part I
 
Management of massive blood loss
Management of massive blood lossManagement of massive blood loss
Management of massive blood loss
 
Blood products and massive blood transfusion
Blood products and massive blood transfusionBlood products and massive blood transfusion
Blood products and massive blood transfusion
 
Surgical Bleeding
Surgical BleedingSurgical Bleeding
Surgical Bleeding
 
Autologous Blood Transfusion
Autologous Blood TransfusionAutologous Blood Transfusion
Autologous Blood Transfusion
 
blood and blood products
blood and blood productsblood and blood products
blood and blood products
 

Similaire à Blood transfusion

Blood transfusion by dr.faisal zia
Blood transfusion by dr.faisal ziaBlood transfusion by dr.faisal zia
Blood transfusion by dr.faisal ziaFaisal Zia
 
Blood Transfusion indications and complications.ppt
Blood Transfusion indications and complications.pptBlood Transfusion indications and complications.ppt
Blood Transfusion indications and complications.pptGVRR
 
6.shockblood transfusion)
6.shockblood transfusion)6.shockblood transfusion)
6.shockblood transfusion)nazimjat
 
Blood Component Therapy: What a clinician needs to know !
Blood Component Therapy: What a clinician needs to know !Blood Component Therapy: What a clinician needs to know !
Blood Component Therapy: What a clinician needs to know !Muskaan Khosla
 
Bb unit2 bloodcomponentsspring2010
Bb unit2 bloodcomponentsspring2010Bb unit2 bloodcomponentsspring2010
Bb unit2 bloodcomponentsspring2010neha goel
 
Blood products 2016
Blood products 2016Blood products 2016
Blood products 2016Eddie Lim
 
Blood transfusion part 1
Blood transfusion part 1Blood transfusion part 1
Blood transfusion part 1Preetam Manoli
 
Blood component therapy in newborn and children jyoti
Blood component therapy in newborn and children jyotiBlood component therapy in newborn and children jyoti
Blood component therapy in newborn and children jyotidr jyoti prajapati
 
Updates on blood transfusion
Updates on blood transfusion Updates on blood transfusion
Updates on blood transfusion Anwar Yusr
 
Blood products:Collection, Processing and Storage of whole human blood, dried...
Blood products:Collection, Processing and Storage of whole human blood, dried...Blood products:Collection, Processing and Storage of whole human blood, dried...
Blood products:Collection, Processing and Storage of whole human blood, dried...Steffi Thomas
 
Blood products.pptx
Blood products.pptxBlood products.pptx
Blood products.pptxJoyful Amon
 
Blood Component Therapy
Blood Component TherapyBlood Component Therapy
Blood Component TherapyDr r k Bishnoi
 
Blood Transfusion (Principles and procedure)
Blood Transfusion (Principles and procedure)Blood Transfusion (Principles and procedure)
Blood Transfusion (Principles and procedure)Boluwatife Afolabi
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusiondrmcbansal
 

Similaire à Blood transfusion (20)

Blood Tranfusion Therapy
Blood Tranfusion TherapyBlood Tranfusion Therapy
Blood Tranfusion Therapy
 
Blood transfusion by dr.faisal zia
Blood transfusion by dr.faisal ziaBlood transfusion by dr.faisal zia
Blood transfusion by dr.faisal zia
 
Blood Transfusion indications and complications.ppt
Blood Transfusion indications and complications.pptBlood Transfusion indications and complications.ppt
Blood Transfusion indications and complications.ppt
 
6.shockblood transfusion)
6.shockblood transfusion)6.shockblood transfusion)
6.shockblood transfusion)
 
Blood substitues
Blood substituesBlood substitues
Blood substitues
 
Blood Component Therapy: What a clinician needs to know !
Blood Component Therapy: What a clinician needs to know !Blood Component Therapy: What a clinician needs to know !
Blood Component Therapy: What a clinician needs to know !
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 
Bb unit2 bloodcomponentsspring2010
Bb unit2 bloodcomponentsspring2010Bb unit2 bloodcomponentsspring2010
Bb unit2 bloodcomponentsspring2010
 
Blood transfusion dr m laban
Blood transfusion dr m laban Blood transfusion dr m laban
Blood transfusion dr m laban
 
Blood products 2016
Blood products 2016Blood products 2016
Blood products 2016
 
Blood transfusion part 1
Blood transfusion part 1Blood transfusion part 1
Blood transfusion part 1
 
Dr. rasel cme final
Dr. rasel cme   finalDr. rasel cme   final
Dr. rasel cme final
 
Blood component therapy in newborn and children jyoti
Blood component therapy in newborn and children jyotiBlood component therapy in newborn and children jyoti
Blood component therapy in newborn and children jyoti
 
Updates on blood transfusion
Updates on blood transfusion Updates on blood transfusion
Updates on blood transfusion
 
Blood products:Collection, Processing and Storage of whole human blood, dried...
Blood products:Collection, Processing and Storage of whole human blood, dried...Blood products:Collection, Processing and Storage of whole human blood, dried...
Blood products:Collection, Processing and Storage of whole human blood, dried...
 
Blood Products 2018
Blood Products 2018Blood Products 2018
Blood Products 2018
 
Blood products.pptx
Blood products.pptxBlood products.pptx
Blood products.pptx
 
Blood Component Therapy
Blood Component TherapyBlood Component Therapy
Blood Component Therapy
 
Blood Transfusion (Principles and procedure)
Blood Transfusion (Principles and procedure)Blood Transfusion (Principles and procedure)
Blood Transfusion (Principles and procedure)
 
Blood transfusion
Blood transfusionBlood transfusion
Blood transfusion
 

Dernier

Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentsaileshpanda05
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 

Dernier (20)

Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
CPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing studentCPR.nursingoutlook.pdf , Bsc nursing student
CPR.nursingoutlook.pdf , Bsc nursing student
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 

Blood transfusion

  • 2. OBJECTIVES  History of blood transfusion  Purposes for blood transfusion  Function and properties of blood  Time of blood transfusion  Blood component  Properties and indication of transfusion for every one  Complications and management of blood transfusion
  • 3. HISTORYHISTORY The science of blood transfusion dates to the first decade of the 19th century, with the discovery of distinct blood types leading to the practice of mixing some blood from the donor and the receiver before the transfusion.  First blood transfusion was done by LOWER in 1665 from dog to dog  In 1901 Sir Austrian Karl Landsteiner discovered blood groups.  He was awarded nobel prize for this discovery in 1930.
  • 4. BLOOD TRANSFUSION  It is a procedure in which a patient receives a blood product through an intravenous line.  It is the introduction of blood components into the venous circulation.  Process of transferring blood-based products from one person into the circulatory system of another.
  • 6. PURPOSES  To replace blood lost during surgery or a serious injury.  To restore oxygen-carrying capacity of the blood.  To provide plasma factors to prevent or treat bleeding.  Done if patient’s body is not capable of making blood properly because of an illness or acute los of blood.
  • 7. FUNCTION AND PROPERTIES OF BLOOD  A vehicular organ that perfuses all other organs  Blood and interstitial fluid deliver nutrients to cells and remove wastes  Haemostatic governors are carried to and from appropriate sites  Blood resembles an average 8% of body weight
  • 8. FUNCTION OF BLOOD • TRANSPORT:  suspended cells include RBCs that carry O2 , One RBCs can carry 1 billion O2 molecule  Platelets that contributes to the haemostatic process ,  Chemicals dissolved in plasma (nutrients, waste, hormones, etc)  metabolic heat for disposal ONE cubic ml of blood contain 400.000 platelets
  • 9. FUNCTION OF BLOOD • REGULATION:  plasma contains pH buffers  plasma water absorbs heat  plasma solutes maintain osmolality
  • 10. FUNCTION OF BLOOD • PROTECTION:  plasma precursor proteins form blood clot when stimulated  suspended WBCs attack bacteria and viruses ( body’s defense )  plasma contains antibodies and opsonins for immunity
  • 12. BEFOR TRANSFUSION WE MUST DETERMINE- W.H.A.T- FOR ANY PROCEDURE
  • 13. Blood transfusions can be grouped into two main types depending on their source:  Homologous transfusions, or transfusions using the stored blood of others.  Autologous transfusions, or transfusions using one's own stored blood. BLOOD TRANSFUSIONBLOOD TRANSFUSION
  • 14. When Hb concentration falls below “acceptable” valuesWhen Hb concentration falls below “acceptable” values and SaO2 is adequate, SVO2 or oxygen extraction ratioand SaO2 is adequate, SVO2 or oxygen extraction ratio may be useful in predicting adequate tissue oxygenationmay be useful in predicting adequate tissue oxygenation 20% loss – no need20% loss – no need 20%-30% loss - plasma substitution20%-30% loss - plasma substitution >30% - Blood transfusion>30% - Blood transfusion WHENE BLOOD TRANSFUTIONWHENE BLOOD TRANSFUTION ))INDICATIONINDICATION((
  • 15. .
  • 16. FRESH WHOLE BLOODFRESH WHOLE BLOOD  Blood that has been drawn recently (within 24 hours) butBlood that has been drawn recently (within 24 hours) but NOT separated into its components.NOT separated into its components.  Contains red blood cells, plasma, clotting cascade factors,Contains red blood cells, plasma, clotting cascade factors, and plateletsand platelets  Anticoagulant (CPDA-1)-63mlAnticoagulant (CPDA-1)-63ml  Hct 35-45% . 1 Unit- 450mlHct 35-45% . 1 Unit- 450ml
  • 17.  Contents of fresh bloodfresh blood o RBC’sRBC’s o WBC’sWBC’s o PlateletsPlatelets o PlasmaPlasma o Clotting factorsClotting factors If refrigerated within 8 hours of collection, store up to 5 days,If refrigerated within 8 hours of collection, store up to 5 days, the product only has RBCs and plasma as platelets becomethe product only has RBCs and plasma as platelets become non-viable at 4oCnon-viable at 4oC Indications  Acute loss of whole bloodAcute loss of whole blood  Massive transfusionMassive transfusion  Cardiovascular bypass surgeryCardiovascular bypass surgery
  • 18. 1. PACKED RED BLOOD CELL ( PRBCs )PACKED RED BLOOD CELL ( PRBCs )  (PRBCs) 1 unit contain (250 ml and Hct.70%)  Healthy, normovolemic individual, tissue oxygenation is maintained and anemia tolerated at Hct as low as 18-25% (Hb 6gm%).  RBC transfusion is rarely indicated when Hb > 10 g/dl and is almost always indicated when Hb < 6 g/dl.  Fastest way to increase the oxygen-delivering capacity of the blood.Fastest way to increase the oxygen-delivering capacity of the blood.  A unit of whole blood or packed red cells will raise the hematocriteA unit of whole blood or packed red cells will raise the hematocrite by 3% and the hemoglobin by 1 gm/dlby 3% and the hemoglobin by 1 gm/dl
  • 19.  RBCs made and destroyed by a rate of 2-3 million per second .  D5W lyses RBC’s.  ONE cubic ml of blood contain 5 million of RBCsONE cubic ml of blood contain 5 million of RBCs  We have approximately 25-30 trillion RBCs in our blood at any given time  Each RBCs has 250 million hemoglobin molecule  Every hemoglobin molecule can hold 4O2 molecule so one RBCs can carry 1 billion O2 molecule  One cubic milliliter of blood has only 5.000-10.000 white WBCs
  • 20. Contents  RBC’s  20% Plasma Indications  Replace O2 carrying capacity with less volume  Severe anemia, slow blood loss, CHF
  • 21. 2. FFP ( initial therapeutic dose : 10-15 ml/kg )( initial therapeutic dose : 10-15 ml/kg )  4-5 units of FFP- in deterioration of normal hemostasis4-5 units of FFP- in deterioration of normal hemostasis Stored at -30 CStored at -30 C (shelf life of 12 months) . Thawed rapidly at 37 C.shelf life of 12 months) . Thawed rapidly at 37 C. ONE unit increase coagulation factors 2-3 %ONE unit increase coagulation factors 2-3 % Infused intravenously through a standard blood set with on-lineInfused intravenously through a standard blood set with on-line filterfilter ABO group must be compatibleABO group must be compatible Infusion of 1 unit should be complete within 4 hr of thawingInfusion of 1 unit should be complete within 4 hr of thawing  ContentsContents Clotting factorsClotting factors FibrinogenFibrinogen  ProthrombinProthrombin Albumin & GlobulinsAlbumin & Globulins
  • 22.  indicationindication  Isolated factor deficienciesIsolated factor deficiencies  Reverse warfarin therapyReverse warfarin therapy  Correction of coagulopathy associated with liver diseaseCorrection of coagulopathy associated with liver disease  Used in patients who are received massive bloodUsed in patients who are received massive blood transfusion with microvascular bleedingtransfusion with microvascular bleeding  Antithrombin III deficiencyAntithrombin III deficiency  TTP ( Thrombotic thrombocytopenic purpura )TTP ( Thrombotic thrombocytopenic purpura ) ## Do not use for volumeDo not use for volume
  • 23. 3. platelets 1 unit (50-70 ml, stored at +20 to +24c for 5 days)1 unit (50-70 ml, stored at +20 to +24c for 5 days)  indicationindication  thrombocytopenia or dysfunction platelets inthrombocytopenia or dysfunction platelets in the presence bleedingthe presence bleeding  prophylactic : plt. counts below 10,000 to 20,000prophylactic : plt. counts below 10,000 to 20,000  prophylacticprophylactic preoperative : plt. counts belowpreoperative : plt. counts below 50,00050,000  Microvascular bleeding in surgical patientMicrovascular bleeding in surgical patient with platelets < 50,000with platelets < 50,000  Neuro/ ocular surgery > 75,000Neuro/ ocular surgery > 75,000
  • 24. 4. Cryoprecipitate4. Cryoprecipitate  Concentrate of factor VIII, von Willebrand’s factor and fibrinogenConcentrate of factor VIII, von Willebrand’s factor and fibrinogen  20 ml containing 150-300 mg of fibrinogen and 80-120 IU of factor VIII20 ml containing 150-300 mg of fibrinogen and 80-120 IU of factor VIII  Stored at -30 C (shelf life 12 month)Stored at -30 C (shelf life 12 month)  Also thawed at 37 CAlso thawed at 37 C  1U/ 10kg1U/ 10kg ↑↑ fibrinogen 50 mg/dL (usually a 6- pack)fibrinogen 50 mg/dL (usually a 6- pack)  Transfusion should be complete within 4 hourTransfusion should be complete within 4 hour indicationsindications  Hemophilia AHemophilia A  Factor XIII deficiencyFactor XIII deficiency Hypofibrinogenemia (congenital or acquired)Hypofibrinogenemia (congenital or acquired) Microvascular bleeding (fibrinogen < 80-100mg/dL)Microvascular bleeding (fibrinogen < 80-100mg/dL)
  • 26. Complication of Blood Transfusion A. Immediate reactions – Febrile reactionFebrile reaction – Allergic reactionsAllergic reactions – Hemolytic transfusion reactionHemolytic transfusion reaction – Circulatory over loadCirculatory over load – Air embolismAir embolism – Potassium toxicityPotassium toxicity – Citrate toxicityCitrate toxicity – Reaction due to infected bloodReaction due to infected blood
  • 27. B-Delayed transfusion reactions ThrombophlebitisThrombophlebitis infectioninfection -- AIDS (HIV) Hepatitis (HBV, HCV)AIDS (HIV) Hepatitis (HBV, HCV) -- Syphilis (Treponema pallidum / Spirochetes)Syphilis (Treponema pallidum / Spirochetes) -- Malaria , C.M.V & otherMalaria , C.M.V & other Immunological sensitization or alloimmunizationImmunological sensitization or alloimmunization Post transfusion purpuraPost transfusion purpura hemolytic transfusion reactions (HTR)hemolytic transfusion reactions (HTR) Complication of massive transfusionComplication of massive transfusion
  • 28. Hemolytic transfusion reactions (HTR) • Incompatibility between donors and recipient 99% of causes is human error and preventable by •  Adequate knowledge of blood groupsAdequate knowledge of blood groups  Careful attention to all details of the techniquesCareful attention to all details of the techniques - blood group incompatibility- blood group incompatibility - outdated and infected blood- outdated and infected blood - Haemolysed blood- Haemolysed blood - Incorrect anticoagulant- Incorrect anticoagulant
  • 29. Chills & rigorsChills & rigors Chest painChest pain Back painBack pain Nausea, vomitingNausea, vomiting Flushing, sweatingFlushing, sweating Pain at infusion sitePain at infusion site Abdominal discomfortAbdominal discomfort Anxiety & RestlessnessAnxiety & Restlessness Symptoms of hemolytic transfusion reactionsSymptoms of hemolytic transfusion reactions
  • 30.  SignsSigns Fever with rigorsFever with rigors TachycardiaTachycardia DyspnoeaDyspnoea TachypnoeaTachypnoea PallorPallor HypotensionHypotension HemoglobinuriaHemoglobinuria Anuria / OliguriaAnuria / Oliguria CyanosisCyanosis Shock & DICShock & DIC Unexplained bleedingUnexplained bleeding
  • 31.  Under anesthesia and sedationUnder anesthesia and sedation  Bleeding from wound / needle sitesBleeding from wound / needle sites  Persistent hypotensionPersistent hypotension  Tachycardia, hyperthermiaTachycardia, hyperthermia Lab evidenceLab evidence  direct antiglobulin test ( DAT ) positivedirect antiglobulin test ( DAT ) positive  Indirect bilirubin increasedIndirect bilirubin increased  HemoglobinemiaHemoglobinemia  HemoglobinuriaHemoglobinuria
  • 32. ManagementManagement  Stop transfusion immediatelyStop transfusion immediately  Maintain IV access with crystalloidMaintain IV access with crystalloid  Maintain BP, pulseMaintain BP, pulse  Ventilation & oxygenationVentilation & oxygenation  IV diuretics - mannitol IVIV diuretics - mannitol IV  frusemide IV bolusfrusemide IV bolus  Send blood samples to blood bank-5ml of plain blood &Send blood samples to blood bank-5ml of plain blood & 2ml of EDTA blood2ml of EDTA blood  CBC and blood pictureCBC and blood picture  Urine sample for hemoglobinuria
  • 33. If intravascular hemolysis is confirmedIf intravascular hemolysis is confirmed  Monitor renal statusMonitor renal status  Monitor coagulation statusMonitor coagulation status  If Hb is markedly reduced ,compatible red cell transfusionIf Hb is markedly reduced ,compatible red cell transfusion may be required to combat hypoxemia.may be required to combat hypoxemia.  Treat DIC if it occursTreat DIC if it occurs
  • 34. Don’ts for Blood TransfusionDon’ts for Blood Transfusion  Don’t use blood without mandatory screening test.Don’t use blood without mandatory screening test.  Don’t delay initiation of blood transfusion.Don’t delay initiation of blood transfusion.  Don’t warm blood without proper monitoring.Don’t warm blood without proper monitoring.  Don’t transfuse 1 unit over more than 4 hours.Don’t transfuse 1 unit over more than 4 hours.  Don’t use 1 transfusion set for >4 hours or >2 units ofDon’t use 1 transfusion set for >4 hours or >2 units of blood.blood.  Don’t leave patients unmonitored.Don’t leave patients unmonitored.  Don’t add any medication to blood bags.Don’t add any medication to blood bags.  Don’t forget to return unused blood to the blood bank forDon’t forget to return unused blood to the blood bank for safe disposal.safe disposal.  Don’t store platelets in a refrigerator.Don’t store platelets in a refrigerator.